Skip to main content
. 2016 Apr;28(2):150–160. doi: 10.21147/j.issn.1000-9604.2016.02.02

Table S2.

Characteristics of risk prediction models in cirrhosis, CHC patients and general population

Factors Risk predictors Prediction risk score in cirrhosis patients (category) Prediction risk score in CHC patients (category)
ADRESS AFP-Based Algorithm (no score) Chang Chang (SVR) Michikawa
No. of model 1 1 1 1 1
CHC, chronic hepatitis C; HCV, hepatitis C virus; CLD, chronic liver disease; BMI, body mass index; DM, diabetes mellitus; Anti-HCV, anti-hepatitis C virus antibody; HBsAg, hepatitis B surface antigen; SVR, sustained virological response; CTP, Child-Turcotte-Pugh; ALT, alanine aminotransferase; AFP, alpha-fetoprotein; AST, serum aspartate transaminase; MET, metabolic equivalent.
Host factors Age years×0.0532 entered as continuous variable 0 (<60 years) 0 (<60 years) 0 (40-49 years)
1 (≥60 years) 5 (≥60 years) 2 (50-59 years)
3 (60-69 years)
Gender 0 (female) 0 (female) 0 (female)
0.5114 (male) 1 (male) 2 (male)
Race 0 (non-Hispanic white)
0.2058 (nonwhite or Hispanic)
BMI 0 (<25 kg/m2)
1 (≥25 kg/m2)
DM 0 (no)
0.2135 (yes)
Environmental factors Alcohol 0 (<450 g/week ethanol or past)
1 (never)
2 (≥450 g/week ethanol)
Virological factors HCV genotype 0 (non G1b) −1 (ribonucleic acid-negative)
1 (G1b) 0 (G2)
2 (G1)
SVR 0 (yes)
2 (no)
Liver-related seromarkers Cirrhosis 0 (autoimmune) 0 (fibrosis stage: 0-2) 0 (fibrosis stage: 0-2)
0.3509 (alcohol/metabolic) 2 (fibrosis stage: 3-4) 6 (fibrosis stage: 3-4)
1.246 (viral)
Severity of CTP CTP score×0.0532 entered as continuous variable
ALT 0 (<30 IU/L)
3 (30-69 IU/L)
5 (≥70 IU/L)
AFP 0 (<20 ng/mL) 0 (<20 ng/mL)
1 (≥20 ng/mL) 4 (≥20 ng/mL)
Platelet 0(≥150×109/L) 0(≥150×109/L)
1(<150×109/L) 4(<150×109/L)
Sum 0-9 0-19 −1-15
Factors Risk predictors Prediction risk score in general population (category)
Michikawa Wen
No. of model 1 9
Host factors Age 0 (40-49 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years)
2 (50-59 years) 2 (40-59 years) 2 (40-59 years) 2 (40-59 years) 2 (40-59 years) 2 (40-59 years) 2 (40-59 years) 2 (40-59 years) 2 (40-59 years) 2 (40-59 years)
3 (60-69 years) 6 (≥60 years) 6 (≥60 years) 6 (≥60 years) 6 (≥60 years) 6 (≥60years) 6 (≥60 years) 6 (≥60 years) 6 (≥60 years) 6 (≥60 years)
Gender 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female)
2 (male) 2 (male) 2 (male) 1 (male) 1 (male) 1 (male) 1 (male) 1 (male)
BMI 0 (<25 kg/m2)
1 (≥25 kg/m2)
Physical activity 0 (<3.75 MET-h) 0 (<7.5 MET-h) 0 (<7.5 MET-h) 0 (<7.5 MET-h)
−1 (≥3.75 MET-h) −1 (≥7.5 MET-h) −1 (≥7.5 MET-h) −1 (≥7.5 MET-h)
DM 0 (no) 0 (no) 0 (no) 0 (no) 0 (no) 0 (no) 0 (no) 0 (no)
1 (yes) 2 (yes) 1 (yes) 1 (yes) 1 (yes) 1 (yes) 1 (yes) 1 (yes)
Environmental factors Smoking 0 (<1 pack-years) 0 (<1 pack-years) 0 (<10 pack-years) 0 (<10 pack-years) 0 (<10 pack-years) 0 (<10 pack-years) 0 (<10 pack-years)
1 (≥1 pack-years) 1 (≥1 pack-years) 1 (≥10 pack-years) 1 (≥10 pack-years) 1 (≥10 pack-years) 1 (≥10 pack-years) 1 (≥10 pack-years)
Alcohol 0 (<450 g/week ethanol) 0 (none or occasional) 0 (none or occasional) 0 (none or occasional) 0 (none or occasional) 0 (none or occasional) 0 (none or occasional) 0 (none or occasional)
1 (never or past) 1 (regular) 1 (regular) 1 (regular) 1 (regular) 1 (regular) 1 (regular) 1 (regular)
2 (≥450 g/week ethanol))
Coffee 0 (almost never to <1 cup/d)
−1 (≥1 cup/d)
Virological factors Anti-HCV 0 (negative) 0 (negative)
6 (positive) 5 (positive)
HBsAg 0 (negative) 0 (negative) 0 (negative) 0 (negative)
4 (positive) 4 (positive) 4 (positive) 6 (positive)
Liver-related seromarkers ALT 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L)
2 (≥25 IU/L) 1 (≥25 IU/L) 1 (≥25 IU/L) 3 (≥25 IU/L) 1 (≥25 IU/L) 2 (≥25 IU/L) 2 (≥25 IU/L)
AFP 0 (<2.5 ng/mL) 0 (<2.5 ng/mL) 0 (<2.5 ng/mL)
1 (2.5-4.9 ng/mL) 2 (2.5-4.9 ng/mL) 2 (2.5-4.9 ng/mL)
4 (5.0-9.9 ng/mL) 5 (5.0-9.9 ng/mL) 5 (5.0-9.9 ng/mL)
8 (≥10.0 ng/mL) 9 (≥10.0 ng/mL) 9 (≥10.0 ng/mL)
AST 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L)
5 (25-39 IU/L) 4 (25-39 IU/L) 4 (25-39 IU/L) 4 (25-39 IU/L) 5 (25-39 IU/L) 4 (25-39 IU/L) 4 (25-39 IU/L)
9 (40-59 IU/L) 9 (40-59 IU/L) 7 (≥40 IU/L) 8 (40-59 IU/L) 8 (40-59 IU/L) 6 (40-59 IU/L) 6 (40-59 IU/L)
13 (≥60 IU/L) 12 (≥60 IU/L) 11 (≥60 IU/L) 11 (≥60 IU/L) 8 (≥60 IU/L) 7 (≥60 IU/L)
Sum −1-19 −1-12 0-23 −1-23 −1-30 −1-10 0-21 0-21 0-32 0-39
Factors Risk predictors Prediction risk score in general population (category)
Hung
No. of model 4
Host factors Age 0 (20-39 years) 0 (20-39 years) 0 (20-39 years) 0 (20-39 years)
3 (40-49 years) 3 (40-49 years) 3 (40-49 years) 3 (40-49 years)
5 (50-59 years) 5 (50-59 years) 5 (50-59 years) 5 (50-59 years)
7 (≥60 years) 7 (≥60 years) 7 (≥60 years) 7 (≥60 years)
Gender 0 (female) 0 (female) 0 (female) 0 (female)
3 (male) 3 (male) 3 (male) 3 (male)
First-degree family history of HCC 0 (no) 0 (no) 0 (no)
2 (yes) 2 (yes) 2 (yes)
Environmental factors Smoking 0 (<18 pack-years) 0 (<18 pack-years) 0 (<18 pack-years)
1 (≥18 pack-years) 1 (≥18 pack-years) 1 (≥18 pack-years)
Virological factors HBsAg or Anti-HCV 0 (negative)
9 (positive)
HBsAg 0 (negative)
7 (positive)
Liver-related seromarkers ALT 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L) 0 (<25 IU/L)
3 (≥25 IU/L) 3 (≥25 IU/L) 3 (≥25 IU/L) 3 (≥25 IU/L)
Previous CLD 0 (no) 0 (no) 0 (no)
3 (yes) 3 (yes) 3 (yes)
Sum 0-13 0-19 0-26 0-28